Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05317884 · ClinicalTrials.gov registry record · NA
Email-based Reminders Promoting Recommended Pediatric Preventative Visits
A NA study, sponsored by Geisinger Clinic.
- Completed
- Registry status
- NA
- Development phase
- 1,186
- Enrollment target
NCT05317884: Completed NA study, sponsored by Geisinger Clinic.
NCT05317884 is a NA study that has completed, run by Geisinger Clinic. The registered enrollment target is 1,186 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (16% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05317884, a NA study, has completed, sponsored by Geisinger Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,186 participants
- Enrollment target
Study Summary
The purpose of this study is to assess, prospectively, the effect of email reminders for well-child check (WCC) visits on adherence to these visits among those who have not yet scheduled the visit. The investigators hypothesize that sending reminders will increase scheduling WCC visits, attending WCC visits, and being up to date for the child's required immunizations beyond what occurs in the absence of these reminders.
Primary Outcome
Binary variable of scheduling a WCC visit as established by visit type, visit reasons, and billing codes (if available)
Interventions
- BEHAVIORAL Reminder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,186 participants |
| Start Date | 2022-05-16 |
| Est. Completion | 2022-09-13 |
| Phase | NA |
What the finished NCT05317884 record still lists
NCT05317884 is an interventional study that assigns participants to a tested intervention. Its 1,186 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (16% lower).
The record links to 0 conditions, and to 1 intervention - of which Reminder is the first listed.
NCT05317884 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05317884 about?
NCT05317884 is a clinical study titled "Email-based Reminders Promoting Recommended Pediatric Preventative Visits". The purpose of this study is to assess, prospectively, the effect of email reminders for well-child check (WCC) visits on adherence to these visits among those who have not yet scheduled the visit. The investigators hypothesize that sending reminders will increase scheduling WCC visits, attending WC...
What is the current status of trial NCT05317884?
This trial is currently completed. It is a NA study. The enrollment target is 1,186 participants. The study started on 2022-05-16. Estimated completion is 2022-09-13.
What interventions are being tested in trial NCT05317884?
The interventions under investigation include: Reminder (BEHAVIORAL).
Who is sponsoring clinical trial NCT05317884?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05317884's enrollment target sits among peer trials
1,186 89th of 2000 higher than 1,912 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04293562 · 1,186 participants · Phase 3
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
- NCT05580419 · 1,188 participants · NA
Impact of 4PCP on Practitioner and Patient Outcomes
- NCT06290869 · 1,188 participants · Phase 3
Tobacco Education and Lung Health Study (TEAL)
- NCT07286058 · 1,182 participants · Phase 3
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI